n/a
Article Publish Status: FREE
Abstract Title:

Royal jelly peptides: potential inhibitors ofβ-secretase in N2a/APP695swe cells.

Abstract Source:

Sci Rep. 2019 Jan 17 ;9(1):168. Epub 2019 Jan 17. PMID: 30655564

Abstract Author(s):

Xueqing Zhang, Yi Yu, Ping Sun, Zhen Fan, Wensheng Zhang, Chengqiang Feng

Article Affiliation:

Xueqing Zhang

Abstract:

Royal jelly (RJ) is a type of natural health product with a long history of use. Royal jelly peptides (RJPs) obtained from RJ have numerous bioactivities. To study the neuroprotective effect of RJPs, major royal jelly proteins were digested into crude RJPs and subsequently purified by RP-HPLC. Purified RJP fractions were evaluated in N2a/APP695swe cells. Our results indicated that purified royal jelly peptides (RJPs) (1-9 μg/mL) could inhibit external beta-amyloid 40 (Aβ) and beta-amyloid 42 (Aβ) production through the down-regulation ofβ-secretase (BACE1) in N2a/APP695 cells. The modulation of BACE1 may be related to histone acetylation modification. Our results demonstrated a neuroprotective function of RJPs, which indicates that RJPs may serve as potential β-secretase inhibitors in ameliorating Aβ-related pathology in Alzheimer's Disease.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.